MyFinsight
Home
About
Contact
Back
Income Statement
ANI PHARMACEUTICALS INC (ANIP)
source: myfinsight.com
Download
Download image
Sales Of Cortrophin
Gel
$81,647K
Sales Of ILUVIENAnd
YUTIQ
$22,316K
Sales Of Generic
Pharmaceutical Products
$90,297K
Sales Of Royalties And
Other Pharmaceutical...
$3,916K
Sales Of Established
Brands
$13,195K
Total Sales Of Rare
Disease Pharmaceutical...
$103,963K
Total Sales Of
Generics And Other
$94,213K
Total Sales Of Rare
Disease And Brands
$117,158K
Net revenues
$211,371K
(53.12%↑ Y/Y)
Unrealized gain (loss) on
investment in equity...
$332K
(112.24%↑ Y/Y)
Operating income
$13,892K
(168.76%↑ Y/Y)
Other income
(expense), net
$1,739K
(2076.14%↑ Y/Y)
Total operating
expenses, net
$197,479K
(48.62%↑ Y/Y)
Income (loss) before
income tax expense
$10,525K
(560.21%↑ Y/Y)
Interest expense, net
-$5,438K
(-16.80%↓ Y/Y)
Contingent consideration
fair value...
$1,277K
(255.71%↑ Y/Y)
Cost of sales
(excluding depreciation...
$74,615K
(29.32%↑ Y/Y)
Depreciation and
amortization
$23,281K
(58.41%↑ Y/Y)
Research and development
$16,535K
(126.63%↑ Y/Y)
Selling, general, and
administrative
$81,771K
(54.81%↑ Y/Y)
Net income (loss)
$8,549K
(473.81%↑ Y/Y)
Income tax expense
$1,976K
Net income (loss)
available to common...
$8,142K
(402.23%↑ Y/Y)
Dividends on series a
convertible preferred stock
$407K
(0.00%↑ Y/Y)
Back